Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Skubal, in his final year of team control, is set to hit the open market this winter. The industry consensus is that the two-time Cy Young will break the record for the biggest co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results